4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
Active, not recruiting · NCT04517149 · Registry updated 2025-03-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) | X-Linked Retinitis Pigmentosa | Active, not recruiting | Phase 1 / Phase 2 | 2025-03-21 | NCT04517149 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 4D Molecular Therapeutics | 10 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Casey Eye Institute, Oregon Health and Science University | Portland | United States | 1 |
| Columbia University Medical Center/Edward Harkness Eye Institute | New York | United States | 1 |
| Duke University Eye Center/Dept. of Ophthalmology | Durham | United States | 1 |
| Retina Foundation of the Southwest | Dallas | United States | 38 |
| University of Colorado | Aurora | United States | 147 |
| University of Michigan Kellogg Eye Center | Ann Arbor | United States | 9 |
| University of Utah John A. Moran Eye Center | Salt Lake City | United States | 4 |
| Vitreo Retinal Associates | Gainesville | United States | 10 |